Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults
Status:
Completed
Trial end date:
2017-03-11
Target enrollment:
Participant gender:
Summary
This is a multicentric, prospective pilot trial testing a Clofarabine-Cyclophosphamide
combination to treat refractory and first bone marrow relapse adult ALL, for the achievement
of a complete remission (CR) and the concurrent evaluation of biological response in ALL
cells (minimal residual disease, apoptosis and DNA cell damage, pharmacogenomics).